IMF (Innogenetics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIMF (Innogenetics)
Drug Alias NameIMF
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsInflammationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujirebio Europe NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujirebio Europe NV
Active IndicationsN/A
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A